Gene · 23545
ATP6V0A2: ATPase H+ transporting V0 subunit a2
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. ATP6V0A2: ATPase H+ transporting V0 subunit a2. Genes, record 23545. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23545
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y487 | V-type proton ATPase 116 kDa subunit a 2 | 856 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents20
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026067851 A | 2026-04-21 | 203 | Q9Y487 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38304 | Q9Y487 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 526 | Q9Y487 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 526 | Q9Y487 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 7520 | Q9Y487 | Espacenet |
| JP 2023521663 A | 2023-05-25 | 202 | Q9Y487 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 7520 | Q9Y487 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 3782 | Q9Y487 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 110491 | Q9Y487 | Espacenet |
| JP 2021530985 A | 2021-11-18 | 310 | Q9Y487 | Espacenet |
1 to 10 of 20
See all 20 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,378
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ATP6V0A2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 4 | 2025 |
| R35GM145256 | Regulation and Cellular Functions of V-ATPases | 4 | 2025 |
| P01CA018029 | Adult Leukemia Research Center | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P30DK056350 | Nutrition Obesity Research Center (NORC) | 3 | 2025 |
| R01DK099551 | New Congenital Disorders of Glycosylation: Therapy and Models | 3 | 2025 |
| R01GM129325 | ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling | 3 | 2025 |
| ZIABC011490 | Maintaining cell health by targeted protein degradation | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 1,378Source NIH's project files
See all 1,378 nih grantsPapers1,638
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnosis of Congenital Disorders of Glycosylation Type II Subtypes Through Comprehensive N-Glycan Profiling by Mass Spectrometry. | Int J Mol Sci | 2026 | 42511652 | PubTator, text mining | PubMed |
| Variant-specific RNA testing resolves variants of uncertain significance in exome testing. | BMC Genomics | 2026 | 42380775 | PubTator, text mining | PubMed |
| ATP6V1B2 alleviates hepatic steatosis by promoting lysosomal acidification in hepatocytes. | Cell Death Discov | 2026 | 41876447 | PubTator, text mining | PubMed |
| Alternative polyadenylation links RNA processing to iron metabolism in human erythropoiesis. | Nucleic Acids Res | 2026 | 41805127 | PubTator, text mining | PubMed |
| Recognition and remodelling of nucleosomes and hexasomes by the human INO80 complex. | Nucleic Acids Res | 2026 | 41775336 | PubTator, text mining | PubMed |
| Microautophagy: current understanding of its molecular mechanisms and functions. | Autophagy Rep | 2026 | 41756808 | PubTator, text mining | PubMed |
| A fully human IgG1 antibody targeting MICA α1 domain inhibits interaction with NKG2D and activates immune effector functions against MICA-expressing cells. | Front Immunol | 2026 | 41756291 | PubTator, text mining | PubMed |
| Pathophysiological Roles of Two Intracellular P-Type ATPases: The Cancer-Associated Na+,K+-ATPase α3 Isoform and the Parkinson's Disease-Related ATP13A2. | Int J Mol Sci | 2026 | 41751935 | PubTator, text mining | PubMed |
| Progress in the Expression, Purification, and Characterization of Recombinant Collagen. | Bioengineering (Basel) | 2026 | 41749699 | PubTator, text mining | PubMed |
| Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells. | Cancer Cell Int | 2026 | 41736030 | PubTator, text mining | PubMed |
1 to 10 of 1,638
See all 1,638 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23545
GET https://conductscience.org/api/genes/v1/23545/patents